Procedures and compositions for treating symptoms associated with posttraumatic stress disorder with cyclobenzaprine

摘要

A pharmaceutical composition comprising cyclobenzaprine in a therapeutically effective amount and a therapeutically effective vehicle, for use in a procedure to treat the development of a symptom of posttraumatic stress disorder (PTSD), or the onset of a symptom of PTSD, or consolidation of a PTSD symptom, or the perpetuation of a PTSD symptom after a traumatic event comprising administering said pharmaceutical composition to a human being in need of said treatment, in which said treatment eliminates or improves the PTSD symptom, in the that the therapeutically effective amount of cyclobenzaprine administered is between 0.5 mg and 50 mg / day.